CORD-19:775b90287b44353bee979abb0970a4666022f86d / 750304-750446 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"The first-in-human (FIH) study (NCT00986037) was a single center, randomized, double-blind, placebo-controlled, 3-part, dose escalation study.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T60591","span":{"begin":0,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T60591","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T187","span":{"begin":0,"end":142},"obj":"Sentence"}],"attributes":[{"subj":"T187","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5682","span":{"begin":20,"end":23},"obj":"Disease"},{"id":"T68152","span":{"begin":20,"end":23},"obj":"Disease"}],"attributes":[{"id":"A5682","pred":"mondo_id","subj":"T5682","obj":"http://purl.obolibrary.org/obo/MONDO_0007796"},{"id":"A35928","pred":"mondo_id","subj":"T68152","obj":"http://purl.obolibrary.org/obo/MONDO_0007796"},{"subj":"T5682","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T68152","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d9ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ece593"},{"id":"CORD-19-PD-MONDO","color":"#cb93ec"}]}]}}